Abstract
Previous, retrospective single institutional and registry analyses have suggested that pre-existing central nervous system (CNS) involvement was not a contraindication for AHCT for patients with non-Hodgkin lymphoma (NHL). We analyzed the outcomes of 151 (64% male) adult recipients of AHCT with NHL and CNS involvement identified at any time prior to transplant and compared them to 4688 AHCT with no CNS lymphoma involvement during the years 1990-2005. Median follow-up of survivors was 77 months. Significant baseline differences were noted between the groups.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
